We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In OASIS 1, adults with obesity lost more than 15% of ...

Add Yahoo as a preferred source to see more of our stories on Google. On Monday the U.S. Food and Drug Administration (FDA) announced that it has cleared the way for the first medical device that ...

Please provide your email address to receive an email when new articles are posted on . The benefits of type 1 diabetes screening have long been up for debate, but FDA approval of the first therapy to ...

ORLANDO, Fla. — The inhaled insulin Afrezza combined with a long-acting basal analog offers a non-inferior insulin treatment option for people with type 1 diabetes, new phase 4 data suggest. Afrezza ...

Rybelsus is a glucagon-like peptide receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The Food and Administration (FDA) ...